Clinical Trial

Passive Leg Raising in Term Pregnancy on Hemodynamic Monitoring - Validating With Transthoracic ECHO (LG-ECHO)

Study acronym: (LG-ECHO)

Withdrawn

View on ClinicalTrials.gov →

Why the trial stopped

The study was withdrawned because of lack of relevant devices in the study center

Summary

This prospective observational validation study aims to evaluate the agreement and diagnostic accuracy of ClearSight™ compared with transthoracic echocardiography (TTE) during PLR in term pregnant women. The ultimate goal is to determine whether ClearSight™ can reliably identify preload responsiveness in term pregnant women compared with the echocardiographic gold standard. The clinical implication is that, if validated, ClearSight™ may reduce unnecessary or harmful fluid administration by accurately detecting preload reserve, and improve maternal safety in peripartum care by providing obstetric anesthesiologists with reliable bedside monitoring tools.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2025-11-19; most recent amendment 2026-01-27.

Status change: Not Yet Recruiting → Withdrawn 2026-01-27

Status change: Recruiting → Not Yet Recruiting 2025-12-18

Status change: Not Yet Recruiting → Recruiting 2025-12-17

Trial Details

NCT Number	NCT07253818
Lead Sponsor	Ayse Zeynep Turan Civraz
Conditions	Maternity, Pregnancy, Labor and Delivery, Hemodynamic Changes
Start Date	2026-01-01
Primary Completion	2026-05-30 (estimated)
Study Completion	2026-07-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-29